AVTR appoints Ludovic Brellier to drive enterprise-wide transformation and oversee its Bioscience & Medtech Products segment starting May 1.
Avantor Inc. (NYSE:AVTR) has appointed Ludovic Brellier as Executive Vice President and Chief Transformation Officer, effective May 1. Brellier will lead the company’s Revival Management Office and oversee the Bioscience & Medtech Products (BMP) business, focusing on growth and operational performance.
Brellier joins from Danaher, where he served as President of Cytiva’s Hardware Solutions business. His background includes leadership roles in biopharma innovation and the integration of Pall Life Sciences into Cytiva. Current BMP head Milkovasa/Benoit Gourdier will remain until the end of 2026 to ensure a smooth transition.
Avantor CEO Emmanuel Ligner highlighted Brellier’s expertise in business transformation, stating it will support long-term growth and maximize the potential of the company’s product brands.